Development of Celiac Disease Therapeutics: Report of the Third Gastroenterology Regulatory Endpoints and Advancement of Therapeutics Workshop.
作者信息
Leffler Daniel, Kupfer Sonia S, Lebwohl Benjamin, Bugin Kevin, Griebel Donna, Lathrop Julia Tait, Lee Jessica J, Mulberg Andrew E, Papadopoulos Elektra, Tomaino Juli, Crowe Sheila E
机构信息
Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Department of Medicine, University of Chicago, Chicago, Illinois.
出版信息
Gastroenterology. 2016 Sep;151(3):407-11. doi: 10.1053/j.gastro.2016.07.025. Epub 2016 Jul 25.
PMID:27456385
Abstract
摘要
相似文献
1
Development of Celiac Disease Therapeutics: Report of the Third Gastroenterology Regulatory Endpoints and Advancement of Therapeutics Workshop.乳糜泻治疗方法的进展：第三届胃肠病学监管终点与治疗进展研讨会报告
Gastroenterology. 2016 Sep;151(3):407-11. doi: 10.1053/j.gastro.2016.07.025. Epub 2016 Jul 25.
2
Development of Celiac Disease Therapeutics: The Sixth Gastroenterology Regulatory Endpoints and the Advancement of Therapeutics Workshop.乳糜泻治疗方法的发展：第六届胃肠病学监管终点与治疗进展研讨会
Gastro Hep Adv. 2022 Nov 8;2(3):294-297. doi: 10.1016/j.gastha.2022.11.006. eCollection 2023.
3
Cancer Therapy: Shooting for the Moon.癌症治疗：向月球进发。
Clin Pharmacol Ther. 2017 May;101(5):552-558. doi: 10.1002/cpt.655.
4
[Frontier Pharmaceutics to Be Explored by Young Scientists: DDS Research for Innovative Drug Development].青年科学家探索前沿药剂学：用于创新药物研发的药物递送系统研究
Yakugaku Zasshi. 2016;136(1):37-8. doi: 10.1248/yakushi.15-00227-F.
5
[Steroid therapy of celiac disease in children].[儿童腹腔疾病的类固醇疗法]
Rev Chil Pediatr. 1974 Sep-Oct;45(5):421-5.
6
[How to adapt to the requirements of "clinical value-oriented drug innovation" for pharmaceutical research in application process of new traditional Chinese medicine].[在中药新药研发应用过程中，如何适应“临床价值导向的药物创新”要求进行药学研究]
Zhongguo Zhong Yao Za Zhi. 2017 May;42(9):1797-1802. doi: 10.19540/j.cnki.cjcmm.20170321.001.
7
Thoughts for 2017.2017年的思考。
Int J Pharm Pract. 2017 Feb;25(1):1-2. doi: 10.1111/ijpp.12309.
8
Impact of COVID-19 on pharmaceutical external innovation sourcing.2019冠状病毒病对制药行业外部创新资源获取的影响。
Nat Rev Drug Discov. 2020 Dec;19(12):829. doi: 10.1038/d41573-020-00184-z.
9
Gluten-free drugs for celiac disease patients.适用于乳糜泻患者的无麸质药物。
Med Lett Drugs Ther. 2008 Mar 10;50(1281):19-20.
10
Current Status of Celiac Disease Drug Development.乳糜泻药物研发的现状
Am J Gastroenterol. 2016 Jun;111(6):779-86. doi: 10.1038/ajg.2016.105. Epub 2016 Mar 29.
引用本文的文献
1
Development of the celiac disease symptom diary version 2.1 (CDSD 2.1) patient-reported outcome measure.开发腹腔疾病症状日记第 2.1 版（CDSD 2.1）患者报告结局测量工具。
Qual Life Res. 2024 Dec;33(12):3275-3282. doi: 10.1007/s11136-024-03799-6. Epub 2024 Oct 26.
2
Emerging Pharmaceutical Therapies to Address the Inadequacy of a Gluten-Free Diet for Celiac Disease.应对无麸质饮食对乳糜泻治疗不足的新兴药物疗法。
Pharmaceuticals (Basel). 2023 Dec 20;17(1):4. doi: 10.3390/ph17010004.
3
A Composite Morphometric Duodenal Biopsy Mucosal Scale for Celiac Disease Encompassing Both Morphology and Inflammation.用于乳糜泻的复合形态计量十二指肠黏膜活检黏膜评分，涵盖形态和炎症。
Clin Gastroenterol Hepatol. 2024 Jun;22(6):1238-1244.e3. doi: 10.1016/j.cgh.2023.10.031. Epub 2023 Nov 11.
4
Quantification of Celiac Disease Severity Using Video Capsule Endoscopy: A Comparison of Human Experts and Machine Learning Algorithms.应用视频胶囊内镜定量检测乳糜泻严重程度：人类专家与机器学习算法的比较。
Curr Med Imaging. 2023;19(12):1455-1662. doi: 10.2174/1573405619666230123110957.
5
Society for the Study of Celiac Disease position statement on gaps and opportunities in coeliac disease.乳糜泻研究学会关于乳糜泻空白和机遇的立场声明。
Nat Rev Gastroenterol Hepatol. 2021 Dec;18(12):875-884. doi: 10.1038/s41575-021-00511-8. Epub 2021 Sep 15.
6
Latiglutenase Treatment for Celiac Disease: Symptom and Quality of Life Improvement for Seropositive Patients on a Gluten-Free Diet.拉替谷蛋白酶治疗乳糜泻：对采用无麸质饮食的血清学阳性患者症状及生活质量的改善情况
GastroHep. 2019 Nov;1(6):293-301. doi: 10.1002/ygh2.371. Epub 2019 Oct 8.
7
Gluten immunogenic peptide excretion detects dietary transgressions in treated celiac disease patients.麸质免疫原性肽排泄可检测接受治疗的乳糜泻患者的饮食违规情况。
World J Gastroenterol. 2019 Mar 21;25(11):1409-1420. doi: 10.3748/wjg.v25.i11.1409.
8
(Outcome) Measure for (Intervention) Measures: A Guide to Choosing the Appropriate Noninvasive Clinical Outcome Measure for Intervention Studies in Celiac Disease.（结局）测量（干预）措施：选择适合乳糜泻干预研究的非侵入性临床结局测量的指南。
Gastroenterol Clin North Am. 2019 Mar;48(1):85-99. doi: 10.1016/j.gtc.2018.09.006. Epub 2018 Dec 13.
9
Eliminating Dietary Gluten: Don't Be a "Glutton for Punishment".杜绝饮食中的麸质：别做“自讨苦吃的人”。
Dig Dis Sci. 2018 Jun;63(6):1374-1375. doi: 10.1007/s10620-018-5010-y.
10
Outcome measures in coeliac disease trials: the Tampere recommendations.乳糜泻试验的结局指标：坦佩雷建议。
Gut. 2018 Aug;67(8):1410-1424. doi: 10.1136/gutjnl-2017-314853. Epub 2018 Feb 13.
Zotero 插件